[Skip to Content]
[Skip to Content Landing]
Article
December 16, 1922

THE MODIFIED PNEUMOCOCCUS VACCINE OF ROSENOW

Author Affiliations

Rochester, Minn.

JAMA. 1922;79(25):2104. doi:10.1001/jama.1922.02640250058031

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:  —While a member of the John McCormick Institute for Infectious Diseases, Chicago, I discovered that antibodies appear more rapidly in the blood following the injection of partially autolyzed pneumococci ("pneumococcus antigen") than following the injection of heat-killed pneumococci.Through the cooperation of Dr. Ludvig Hektoen, director of the institute, and of physicians at the Presbyterian and Cook County hospitals, the effect of this antigen on the course of lobar pneumonia, as compared with alternate untreated cases, was studied for three consecutive years. The mortality rate was lower in the treated than in the control series. Subsequent studies have corroborated these results.During my studies on the bacteriology of influenza in 1918-1919, I prepared, from the freshly isolated strains of bacteria, mixed vaccines which appeared to be valuable in prophylactic inoculation against the more serious respiratory infections in influenza.The burden of the preparation and distribution of these

First Page Preview View Large
First page PDF preview
First page PDF preview
×